pemetrexed

Generic: pemetrexed

Labeler: accord healthcare inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name pemetrexed
Generic Name pemetrexed
Labeler accord healthcare inc.
Dosage Form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes
INTRAVENOUS
Active Ingredients

pemetrexed disodium hemipentahydrate 100 mg/4mL

Manufacturer
Accord Healthcare Inc.

Identifiers & Regulatory

Product NDC 16729-229
Product ID 16729-229_1d874430-c6ce-cff2-e063-6394a90a4a49
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA203485
Listing Expiration 2026-12-31
Marketing Start 2022-05-25

Pharmacologic Class

Classes
folate analog metabolic inhibitor [epc] folic acid metabolism inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 16729229
Hyphenated Format 16729-229

Supplemental Identifiers

RxCUI
1728072 1728077 2601728
UPC
0316729229036 0316729244381 0316729230117
UNII
F4GSH45R4C

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name pemetrexed (source: ndc)
Generic Name pemetrexed (source: ndc)
Application Number ANDA203485 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 100 mg/4mL
source: ndc
Packaging
  • 1 VIAL in 1 CARTON (16729-229-03) / 4 mL in 1 VIAL
source: ndc

Packages (1)

16729-229-03 1 VIAL in 1 CARTON (16729-229-03) / 4 mL in 1 VIAL

Ingredients (1)

pemetrexed disodium hemipentahydrate (100 mg/4mL)

Linked Drug Pages (1)

PEMETREXED ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "1d874430-c6ce-cff2-e063-6394a90a4a49", "openfda": {"upc": ["0316729229036", "0316729244381", "0316729230117"], "unii": ["F4GSH45R4C"], "rxcui": ["1728072", "1728077", "2601728"], "spl_set_id": ["dfd19e67-54cb-c062-e053-2995a90a294a"], "manufacturer_name": ["Accord Healthcare Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 CARTON (16729-229-03)  / 4 mL in 1 VIAL", "package_ndc": "16729-229-03", "marketing_start_date": "20220525"}], "brand_name": "PEMETREXED", "product_id": "16729-229_1d874430-c6ce-cff2-e063-6394a90a4a49", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Folate Analog Metabolic Inhibitor [EPC]", "Folic Acid Metabolism Inhibitors [MoA]"], "product_ndc": "16729-229", "generic_name": "Pemetrexed", "labeler_name": "Accord Healthcare Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "PEMETREXED", "active_ingredients": [{"name": "PEMETREXED DISODIUM HEMIPENTAHYDRATE", "strength": "100 mg/4mL"}], "application_number": "ANDA203485", "marketing_category": "ANDA", "marketing_start_date": "20220525", "listing_expiration_date": "20261231"}